OR4M2-OT1
gene geneOn this page
Summary
OR4M2-OT1 (OR4M2 overlapping transcript 1, HGNC:56199) is a protein-coding gene on chromosome 15q11.2.
At a glance
- Clinical variants (ClinVar): 8 total
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:56199 |
| Approved symbol | OR4M2-OT1 |
| Name | OR4M2 overlapping transcript 1 |
| Location | 15q11.2 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000285472 |
| Ensembl biotype | protein_coding |
| Entrez | 101927079 |
| RNAcentral | URS0002A146AA — lncRNA, 1370 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000639059
RefSeq mRNA: 0 — MANE Select: None
CCDS: CCDS32173
Canonical transcript exons
ENST00000639059 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003801742 | 22094513 | 22095857 |
| ENSE00003803712 | 22058721 | 22058816 |
| ENSE00003807009 | 22015233 | 22015331 |
| ENSE00003808910 | 22059632 | 22059835 |
| ENSE00003810853 | 22044437 | 22044825 |
| ENSE00003816883 | 22030926 | 22031020 |
| ENSE00003822300 | 22059321 | 22059409 |
Expression profiles
Bgee: expression breadth tissue_specific, 7 present calls, max score 78.86.
Top tissues by expression
130 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.86 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 56.61 | silver quality |
| left testis | UBERON:0004533 | 54.31 | gold quality |
| testis | UBERON:0000473 | 54.22 | gold quality |
| right testis | UBERON:0004534 | 53.48 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| liver | UBERON:0002107 | 28.28 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| leukocyte | CL:0000738 | 26.58 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| monocyte | CL:0000576 | 26.48 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.00 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| urinary bladder | UBERON:0001255 | 25.72 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.27 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Canonical reviewed UniProt: None (reviewed: )
All UniProt accessions (1): A0A126GVN2
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 1 (showing top):
chr15q11
GO Biological Process (4): signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608), detection of chemical stimulus involved in sensory perception of smell (GO:0050911)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
8 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 8 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
414 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 15:22095217:G:T | donor_gain | 0.9900 |
| 15:22095349:A:AG | acceptor_gain | 0.8800 |
| 15:22095350:G:GG | acceptor_gain | 0.8800 |
| 15:22080692:TCC:T | donor_gain | 0.8700 |
| 15:22095028:T:TA | acceptor_gain | 0.8500 |
| 15:22095347:ACAGT:A | acceptor_gain | 0.8400 |
| 15:22080746:G:GT | donor_gain | 0.8300 |
| 15:22095217:G:GT | donor_gain | 0.8300 |
| 15:22095349:AGT:A | acceptor_gain | 0.7900 |
| 15:22095350:GTG:G | acceptor_gain | 0.7900 |
| 15:22095350:GT:G | acceptor_gain | 0.7800 |
| 15:22094544:T:TA | donor_gain | 0.7600 |
| 15:22094545:A:AA | donor_gain | 0.7600 |
| 15:22080651:GAC:G | donor_gain | 0.7400 |
| 15:22080652:ACA:A | donor_gain | 0.7400 |
| 15:22095346:C:G | acceptor_gain | 0.7300 |
| 15:22080653:C:G | donor_gain | 0.7200 |
| 15:22080693:C:A | donor_gain | 0.7000 |
| 15:22080747:A:T | donor_gain | 0.7000 |
| 15:22095348:C:G | acceptor_gain | 0.7000 |
| 15:22094586:A:G | donor_gain | 0.6900 |
| 15:22095350:GTGAT:G | acceptor_gain | 0.6700 |
| 15:22080855:A:AG | acceptor_gain | 0.6600 |
| 15:22080856:G:GG | acceptor_gain | 0.6600 |
| 15:22095233:TCC:T | donor_gain | 0.6500 |
| 15:22095237:C:G | donor_gain | 0.6400 |
| 15:22095255:T:G | donor_gain | 0.6400 |
| 15:22080945:T:A | acceptor_gain | 0.6300 |
| 15:22095253:C:A | donor_gain | 0.6100 |
| 15:22095345:A:AG | acceptor_gain | 0.6100 |
AlphaMissense
2086 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 15:22094555:T:C | F12L | 0.856 |
| 15:22094557:T:A | F12L | 0.856 |
| 15:22094557:T:G | F12L | 0.856 |
| 15:22095023:T:C | F168L | 0.840 |
| 15:22095025:T:A | F168L | 0.840 |
| 15:22095025:T:G | F168L | 0.840 |
| 15:22095272:T:C | F251L | 0.780 |
| 15:22095274:T:A | F251L | 0.780 |
| 15:22095274:T:G | F251L | 0.780 |
| 15:22095050:T:C | F177L | 0.763 |
| 15:22095052:C:A | F177L | 0.763 |
| 15:22095052:C:G | F177L | 0.763 |
| 15:22094603:T:C | F28L | 0.741 |
| 15:22094605:T:A | F28L | 0.741 |
| 15:22094605:T:G | F28L | 0.741 |
| 15:22094825:T:C | F102L | 0.716 |
| 15:22094827:T:A | F102L | 0.716 |
| 15:22094827:T:G | F102L | 0.716 |
| 15:22095305:T:C | F262L | 0.715 |
| 15:22095307:C:A | F262L | 0.715 |
| 15:22095307:C:G | F262L | 0.715 |
| 15:22095053:T:C | F178L | 0.705 |
| 15:22095055:C:A | F178L | 0.705 |
| 15:22095055:C:G | F178L | 0.705 |
| 15:22095152:T:C | F211L | 0.663 |
| 15:22095154:T:A | F211L | 0.663 |
| 15:22095154:T:G | F211L | 0.663 |
| 15:22094556:T:C | F12S | 0.652 |
| 15:22095356:T:C | F279L | 0.649 |
| 15:22095358:T:A | F279L | 0.649 |
dbSNP variants (sampled 300 via entrez): RS1000136038 (15:22014626 T>A), RS1000174732 (15:22084006 T>A,C), RS1000579112 (15:20991941 C>G), RS1000778575 (15:22088136 A>G), RS1000863862 (15:20992421 T>G), RS1001152220 (15:22019847 C>T), RS1001470560 (15:20999449 A>G), RS1001473945 (15:22042474 G>A), RS1001738120 (15:22041384 T>C), RS1001818029 (15:20996963 A>G), RS1002158003 (15:22024617 T>C), RS1002188993 (15:22023491 G>A), RS1002404410 (15:20977622 T>C), RS1002512383 (15:22075080 G>T), RS1003225305 (15:22094491 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 0 entries
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.